dipyridamole has been researched along with Coagulation Disorders, Blood in 18 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Indeed, Kawasaki disease is induced by overreaction of innate cells following exposition to various viruses, including herpes viruses which trigger STING." | 2.66 | Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway? ( Berthelot, JM; Drouet, L; Lioté, F, 2020) |
| " In addition, regular heparin (Liquemin; Roche, Indianapolis, IN, USA) was administered at a dosage of 250 microg/kg per hour or 25 IU/kg per hour (6 mg/kg per 24 hours)." | 1.36 | Dipyridamole and low doses of heparin as a new successful physiopathologic and therapeutic approach in 2 cases of disseminated intravascular coagulation. ( Gomes, ES; Gomes, OM, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (77.78) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Berthelot, JM | 1 |
| Drouet, L | 1 |
| Lioté, F | 1 |
| Gomes, OM | 1 |
| Gomes, ES | 1 |
| Hughes, DA | 1 |
| Mehta, AB | 1 |
| Packham, MA | 1 |
| Mustard, JF | 1 |
| Reggiani, E | 1 |
| Odaglia, G | 1 |
| Talalak, P | 1 |
| Chaithiraphan, S | 1 |
| Opartkiattikul, N | 1 |
| Leowattana, W | 1 |
| Sangtawesin, W | 1 |
| Tresukosol, D | 1 |
| Strano, A | 1 |
| Novo, S | 1 |
| Priluck, IA | 1 |
| Jacques, C | 1 |
| Drueke, T | 1 |
| Nedellec, J | 1 |
| Kremp, O | 1 |
| Gazengel, C | 1 |
| de Gaetano, G | 1 |
| Donati, MB | 1 |
| Garattini, S | 1 |
| Maurer, HJ | 1 |
| Harker, LA | 1 |
| Sierakowski, S | 1 |
| Sherry, S | 2 |
| Mosesson, MW | 1 |
| Colman, RW | 1 |
| Brochier, M | 1 |
| Griguer, P | 1 |
| Dziewolska, M | 1 |
| Krug, H | 1 |
| Adura, M | 1 |
| Guerra, JC | 1 |
7 reviews available for dipyridamole and Coagulation Disorders, Blood
| Article | Year |
|---|---|
Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway?
Topics: Angiotensin II; Animals; Aspirin; Blood Coagulation Disorders; Coronavirus Infections; COVID-19; Dip | 2020 |
Vascular complications of Fabry disease: enzyme replacement and other therapies.
Topics: alpha-Galactosidase; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspirin; Blood Coagulati | 2005 |
Platelet adhesion.
Topics: Animals; Arachidonic Acids; Basement Membrane; Blood Coagulation; Blood Coagulation Disorders; Blood | 1984 |
[Prospects of antiaggregant therapy in prevention of atherosclerosis].
Topics: Animals; Anti-Inflammatory Agents; Anticoagulants; Arteriosclerosis; Aspirin; Blood Coagulation Diso | 1979 |
Antiplatelet drugs in the management of patients with thrombotic disorders.
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Blood Coagulation Disorders; Blood Platelets | 1986 |
[New theories on the pathogenesis and methods of treating thrombotic thrombocytopenic purpura (Moschkowitz disease)].
Topics: Adolescent; Adult; Aspirin; Blood Coagulation Disorders; Child; Dipyridamole; Epoprostenol; Female; | 1986 |
Clinical aspects of antiplatelet therapy.
Topics: Angina Pectoris; Aspirin; Blood Coagulation Disorders; Clinical Trials as Topic; Dipyridamole; Femal | 1985 |
3 trials available for dipyridamole and Coagulation Disorders, Blood
| Article | Year |
|---|---|
Laboratory assessment of thrombolytic therapy in acute myocardial infarction.
Topics: Blood Coagulation Disorders; Blood Coagulation Tests; Dipyridamole; Drug Monitoring; Drug Therapy, C | 1993 |
[Disorders of haemostasis in patients undergoing maintenance haemodialysis, with special reference to recurrent arteriovenous fistula thrombosis. Effects of dipyridamole (author's transl)].
Topics: Adenosine Diphosphate; Adult; Arteriovenous Shunt, Surgical; Blood Coagulation Disorders; Blood Plat | 1976 |
Clinical aspects of antiplatelet therapy.
Topics: Angina Pectoris; Aspirin; Blood Coagulation Disorders; Clinical Trials as Topic; Dipyridamole; Femal | 1985 |
9 other studies available for dipyridamole and Coagulation Disorders, Blood
| Article | Year |
|---|---|
Dipyridamole and low doses of heparin as a new successful physiopathologic and therapeutic approach in 2 cases of disseminated intravascular coagulation.
Topics: Adolescent; Anticoagulants; Blood Coagulation Disorders; Child; Dipyridamole; Drug Combinations; Hep | 2010 |
[Blood coagulation processes in decompression sickness and hyperbaric therapy].
Topics: Antioxidants; Arachidonic Acid; Arachidonic Acids; Blood Coagulation Disorders; Decompression Sickne | 1981 |
Impending central retinal vein occlusion associated with increased platelet aggregability.
Topics: Anticoagulants; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platelets; Dipyridamole; | 1979 |
Drugs affecting platelet function tests: their effects on haemostasis and surgical bleeding.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Coagulation Disorders; Blood Donors; Blood P | 1975 |
[Coagulation disorder following angiography with a nonionic tri-iodized contrast medium? Effect due to contrast medium or to heparin?].
Topics: Aortography; Aspirin; Aspirin, Dipyridamole Drug Combination; Blood Coagulation Disorders; Blood Coa | 1985 |
Chronic intravascular coagulation syndrome.
Topics: Beta-Globulins; Blood Cell Count; Blood Coagulation Disorders; Blood Coagulation Tests; Blood Platel | 1968 |
[Hyperaggregation effects of thrombolytic enzymes].
Topics: Blood Coagulation Disorders; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Heparin; | 1973 |
[Role of thrombotic agent in coronary insufficiency--therapeutic implications (author's transl)].
Topics: Arteriosclerosis; Aspirin; Blood Coagulation Disorders; Blood Platelet Disorders; Coronary Disease; | 1974 |
[Positive effect of dipyridamol on a intrinsic coagulation].
Topics: Adult; Animals; Blood Coagulation Disorders; Dipyridamole; Female; Guinea Pigs; Humans; Male; Middle | 1967 |